2009
DOI: 10.1016/j.jamcollsurg.2009.09.022
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Spectrum of Pheochromocytoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

16
128
5
9

Year Published

2009
2009
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 155 publications
(158 citation statements)
references
References 11 publications
16
128
5
9
Order By: Relevance
“…Metachronous metastases occurred on average 49.4 months (range, 5.9-194.8 months) postoperatively. The locations of recurrent disease were liver (6), bone (4), lung and pleura (4), and bladder (1). Patients were diagnosed with pheochromocytoma, either benign or malignant, within 0.02 months to 7.2 years (median, 1.8 years) from the onset of symptoms.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Metachronous metastases occurred on average 49.4 months (range, 5.9-194.8 months) postoperatively. The locations of recurrent disease were liver (6), bone (4), lung and pleura (4), and bladder (1). Patients were diagnosed with pheochromocytoma, either benign or malignant, within 0.02 months to 7.2 years (median, 1.8 years) from the onset of symptoms.…”
Section: Resultsmentioning
confidence: 99%
“…Pheochromocytoma is a catecholamine-secreting tumor that emerges from the chromaffin cells of the adrenal medulla, usually manifesting as a benign tumor but occasionally becoming malignant [1,2]. Because the long-term prognosis of patients with malignant pheochromocytoma is unclear or poor, identification of factors associated with malignancy could aid in modifying follow-up plans and could enhance disease-specific survival.…”
Section: Introductionmentioning
confidence: 99%
“…Pheochromocytoma symptoms result from the uncontrolled release of catecholamines: norepinephrine, epinephrine, and rarely dopamine (1)(2)(3)(4)(5). Compared with norepinephrine release, epinephrine has a predominant effect on b2-adrenoreceptors of the vessel muscles resulting in vasodilation and postural hypotension (1,2,5).…”
mentioning
confidence: 99%
“…Compared with norepinephrine release, epinephrine has a predominant effect on b2-adrenoreceptors of the vessel muscles resulting in vasodilation and postural hypotension (1,2,5). Norepinephrine release acts predominantly on b1-and a1-adrenoreceptors resulting in vasoconstriction and hypertension (1,2,5).…”
mentioning
confidence: 99%
See 1 more Smart Citation